Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
57:46
January 16, 2026 - PBS News Hour full episode
56:46
January 15, 2026 - PBS News Hour full episode
57:46
January 14, 2026 - PBS News Hour full episode
57:46
January 13, 2026 - PBS News Hour full episode
57:46
January 12, 2026 - PBS News Hour full episode
26:52
January 11, 2026 - PBS News Weekend full episode
26:44
January 10, 2026 - PBS News Weekend full episode
56:44
January 9, 2026 - PBS News Hour full episode
57:46
January 8, 2026 - PBS News Hour full episode
57:46
January 7, 2026 - PBS News Hour full episode
56:42
January 6, 2026 - PBS News Hour full episode
57:46
January 5, 2026 - PBS News Hour full episode